Judah Frommer
Stock Analyst at Morgan Stanley
(2.98)
# 497
Out of 5,370 analysts
193
Total ratings
60.80%
Success rate
36.73%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
BPMC Blueprint Medicines | Maintains: Equal-Weight | 102 129 | 128.09 | 0.71% | 2 | Jun 5, 2025 | |
CLDX Celldex Therapeutics | Maintains: Overweight | 46 43 | 20.4 | 110.78% | 2 | May 9, 2025 | |
ABVX Abivax | Assumes: Equal-Weight | 12 | 6.76 | 77.51% | 1 | Mar 20, 2025 | |
RGNX Regenxbio | Maintains: Overweight | 22 24 | 9.14 | 162.58% | 2 | Mar 14, 2025 | |
GLPG Galapagos | Downgrades: Underweight | 31 22 | 28.82 | -23.66% | 3 | Feb 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 8 6 | 4.38 | 36.99% | 2 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 31 | 18.32 | 69.21% | 1 | Nov 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 81 106 | 64.14 | 65.26% | 2 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 35 | 9.95 | 251.76% | 1 | Oct 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 2.46 | 428.46% | 1 | Apr 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 3 | 0.98 | 206.12% | 1 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 40 | 5.62 | 611.74% | 8 | Aug 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 4 | n/a | n/a | 3 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 13 | 1.14 | 1040.35% | 5 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 30 | 29.84 | 0.54% | 8 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 23 | 11.7 | 96.58% | 5 | Aug 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 50 | 51.79 | -3.46% | 9 | Jul 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 141 | 20.99 | 571.75% | 13 | Jun 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 13 | 1.42 | 815.49% | 5 | May 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 9 | 2.23 | 303.59% | 5 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 175 138 | n/a | n/a | 6 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 21 22 | 19.75 | 11.39% | 2 | Apr 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 7 | 5.16 | 35.66% | 3 | Mar 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 1 | n/a | n/a | 4 | Mar 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 8 | 6.79 | 17.82% | 5 | Mar 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 | 14.62 | 214.64% | 5 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 7 7 | 1.17 | 498.29% | 6 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 51 55 | 15.11 | 264% | 3 | Feb 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 | 101.26 | -54.57% | 1 | Feb 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 4 4 | n/a | n/a | 1 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 10 | n/a | n/a | 2 | Oct 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 47 49 | 87.46 | -43.97% | 4 | Nov 5, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 328 370 | 984.1 | -62.4% | 2 | Oct 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 31 | 76.61 | -59.54% | 6 | Sep 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 65 76 | 74.78 | 1.63% | 8 | Sep 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 182 | 113.69 | 60.08% | 6 | Aug 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 107 | 98.9 | 8.19% | 13 | Aug 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 90 95 | 120.8 | -21.36% | 10 | Jul 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 18 | 21.55 | -16.47% | 1 | Jul 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 93 116 | 126.28 | -8.14% | 12 | Jun 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 38 | 108.89 | -65.1% | 4 | May 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 22 | 160.38 | -86.28% | 1 | May 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 33 35 | 66.03 | -46.99% | 9 | Apr 29, 2020 |